Pfizer (PFE) Financials
Pfizer (PFE) Historical Financial Statements and Key Metrics for 1994 - 2021
Full Pfizer financials for 1994 - 2021 are available in the
US Historical Financials dataset
All financial data is sourced direct from SEC 10-Q and 10-K filings, restatements are included.
Pfizer Income Statements
(in $ 000,000's)
| Quarter End | Revenue | Gross Profit | Operating Income | Net Income | EBITDA | EPS |
| 2021-Apr-04 | 14,582 | 10,371 (71.1 %) | 4,702 (32.2 %) | 4,877 (33.4 %) | 5,928 | 0.86 |
| 2020-Dec-31 | 5,947 | 4,443 (74.7 %) | -2,190 (-36.8 %) | 594 (10.0 %) | -1,144 | 0.10 |
| 2020-Sep-27 | 12,131 | 9,602 (79.2 %) | 3,328 (27.4 %) | 2,194 (18.1 %) | 4,590 | 0.39 |
| 2020-Jun-28 | 11,801 | 9,569 (81.1 %) | 3,441 (29.2 %) | 3,426 (29.0 %) | 4,692 | 0.61 |
| 2020-Mar-29 | 12,028 | 9,682 (80.5 %) | 4,588 (38.1 %) | 3,401 (28.3 %) | 5,806 | 0.61 |
| 2019-Dec-31 | 12,688 | 10,080 (79.4 %) | 1,985 (15.6 %) | -336 (-2.6 %) | 3,369 | -0.06 |
| 2019-Sep-29 | 12,680 | 10,225 (80.6 %) | 11,113 (87.6 %) | 7,680 (60.6 %) | 12,666 | 1.36 |
Full historical income statements for 1994 - 2021 is included in the
US Historical Financials dataset.
Pfizer Balance Sheets
(in $ 000,000's)
| Quarter End | Total Assets | Total Liabilities | Total Debt | Total Equity | Cash & Equivalents |
| 2021-Apr-04 | 158,818 | 89,953 | 38,188 | 68,620 | 13,667 |
| 2020-Dec-31 | 154,229 | 90,756 | 38,274 | 63,238 | 12,221 |
| 2020-Sep-27 | 178,983 | 113,488 | 61,528 | 65,259 | 10,499 |
| 2020-Jun-28 | 177,934 | 113,598 | 62,132 | 64,336 | 11,382 |
| 2020-Mar-29 | 166,336 | 101,310 | 51,951 | 65,026 | 10,350 |
| 2019-Dec-31 | 167,489 | 104,042 | 52,145 | 63,143 | 9,830 |
| 2019-Sep-29 | 170,446 | 105,343 | 50,230 | 65,103 | 9,087 |
Full historical balance sheet data for 1994 - 2021 is included in the
US Historical Financials dataset.
Pfizer Cash Flow Statements
(in $ 000,000's)
| Quarter End | Operating Cash Flow | Investing | Financing | Free Cash Flow |
| 2021-Apr-04 | 4,538 | -1,747 | -2,807 | 3,984 |
| 2020-Dec-31 | 5,625 | 8,411 | -13,787 | 4,339 |
| 2020-Sep-27 | 2,090 | 481 | -2,821 | 1,560 |
| 2020-Jun-28 | 3,556 | -13,011 | 9,159 | 3,076 |
| 2020-Mar-29 | 3,132 | -71 | -2,200 | 2,637 |
| 2019-Dec-31 | 3,769 | -2,834 | -2,440 | 3,043 |
| 2019-Sep-29 | 4,508 | -6,760 | 3,273 | 3,846 |
Full historical cash flow data for 1994 - 2021 is included in the
US Historical Financials dataset.
Pfizer Key Valuation and Operating Metrics
| Quarter End | Market Capitalization ($ 000,000's) |
Enterprise Value ($ 000,000's) |
Price/Earnings ($ 000,000's) |
Price/Sales ($ 000,000's) |
Price/Book ($ 000,000's) |
| 2021-Apr-04 | 202,588 | 239,008 | 13.89 | 10.38 | 2.95 |
| 2020-Dec-31 | 204,737 | 241,227 | 34.43 | 86.17 | 3.24 |
| 2020-Sep-27 | 191,859 | 251,800 | 15.82 | 21.86 | 2.94 |
| 2020-Jun-28 | 174,008 | 234,339 | 14.75 | 12.70 | 2.70 |
| 2020-Mar-29 | 173,982 | 223,782 | 14.46 | 12.79 | 2.68 |
| 2019-Dec-31 | 205,751 | 256,591 | 16.22 | -153.09 | 3.26 |
| 2019-Sep-29 | 192,570 | 240,015 | 15.19 | 6.27 | 2.96 |
Full historical valuation and operating metrics for 1994 - 2021 are included in the
US Historical Financials dataset.